Zunveyl is a next-generation acetylcholinesterase inhibitor approved in the U.S. for mild-to-moderate Alzheimer's disease.

Research published Tuesday is the first to connect the dots between a common herpes virus, head injury, and Alzheimer's.

The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

The oral herpes virus appears to be linked with Alzheimer’s disease, suggesting that the common infection might play a role ...

Alzheimer’s disease is the most common cause of dementia in older adults. But according to experts, the condition affects men ...

An international team of scientists has uncovered new insights into how the previously understudied duplicate X chromosome in ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

A new study found a link between cytomegalovirus (CMV) and Alzheimer's disease. Here's what a neurologist wants you to know, ...

Having hope is important in times of uncertainty or adversity and can help people stay motivated and embrace a positive ...

A study of human brain organoids suggested a complex relationship between herpes simplex virus 1 infection and tau, ...

A recent study by Tufts and Oxford universities reveals that head trauma can activate dormant herpes viruses in the brain, ...